Cyclophosphamide and Fludarabine Followed By Laboratory-Treated Donor Lymphocytes and High-Dose Aldesleukin in Treating Patients With Metastatic Melanoma That Did Not Respond to Previous Treatment
This study is currently recruiting participants.
Study NCT00537069.
Last updated on April 9, 2009.
Information provided by National Cancer Institute (NCI)
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
